NIGHTSTAR BIOTECHNOLOGIES, INC

HOUSTON, TX

OncologyCAR-TGrant-only

Compare Sign in to watch

What changed

NIH R01 · $0.5M · Striatal ensemble plasticity in alcohol use disorder

2mo agoGrant renewalMay 5, 2026Source filing (opens the source filing in a new tab)

Momentum

78no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

12,694 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R21 · $455k · non-dilutive
Feb 15, 2026
STATE UNIVERSITY NEW YORK STONY BROOK · PI WANG, JUN · NIA · award ends Jan 31, 2028 · Regulatory Landscape of Neurodegeneration by Single-Cell Spatial Multiomics
NIH RePORTER · NIH RePORTER 11303064 (opens the source filing in a new tab)
Grant
R41 · $360k · non-dilutive
Sep 18, 2025
NIGHTSTAR BIOTECHNOLOGIES, INC · PI WANG, TAO · NCI · award ends Aug 31, 2027 · Design and optimization of TCR-T therapeutics by an advanced T cell receptor-antigen binding prediction platform
NIH RePORTER · NIH RePORTER 11314094 (opens the source filing in a new tab)
Grant
R01 · $686k · non-dilutive
Mar 1, 2025
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WANG, TAO · NIAID · award ends Feb 28, 2030 · Machine learning for identifying antigen-antibody interactions from massive sequencing data
NIH RePORTER · NIH RePORTER 11412803 (opens the source filing in a new tab)
Grant
R01 · $635k · non-dilutive
Mar 1, 2025
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WANG, TAO · NIAID · award ends Feb 28, 2030 · Machine learning for identifying antigen-antibody interactions from massive sequencing data
NIH RePORTER · NIH RePORTER 11293440 (opens the source filing in a new tab)
Grant
R61 · $237k · non-dilutive
Mar 1, 2025
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MA, SAI · NCI · award ends Feb 29, 2028 · High-throughput single-cell joint RNA and DNA methylation mapping of Acute Myeloid Leukemia
NIH RePORTER · NIH RePORTER 11290853 (opens the source filing in a new tab)
Trial
NA registered
Jan 2, 2025
Diabetes · ACTIVE_NOT_RECRUITING · sponsor: Taichung Veterans General Hospital · Point-of-Care Testing in Outpatient Diabetes Care
ClinicalTrials.gov · NCT06684990 (opens the source filing in a new tab)
Grant
R35 · $394k · non-dilutive
Feb 1, 2024
STATE UNIVERSITY NEW YORK STONY BROOK · PI WANG, JUN · NIGMS · award ends Jan 31, 2029 · Advanced Single-Cell Protein Analysis with Multiplex in Situ Tagging Array Technology
NIH RePORTER · NIH RePORTER 11259535 (opens the source filing in a new tab)
Grant
R01 · $452k · non-dilutive
Aug 1, 2023
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WANG, JUN · NIAAA · award ends Apr 30, 2028 · Striatal ensemble plasticity in alcohol use disorder
NIH RePORTER · NIH RePORTER 11336789 (opens the source filing in a new tab)
Grant
R01 · $578k · non-dilutive
Dec 1, 2022
NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WANG, JUN · NCI · award ends Nov 30, 2027 · Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment
NIH RePORTER · NIH RePORTER 11231678 (opens the source filing in a new tab)
Grant
R01 · $615k · non-dilutive
Sep 25, 2018
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WANG, JUN · NHLBI · award ends Nov 30, 2027 · Genetic dissection of Cardiac Conduction System homeostasis and Repair
NIH RePORTER · NIH RePORTER 11237191 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.31semantic similarity 80% · same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.5M · Striatal ensemble plasticity in alcohol use disorder
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R61 · $0.2M · High-throughput single-cell joint RNA and DNA methylation mapping of Acute Myeloid Leukemia
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Genetic dissection of Cardiac Conduction System homeostasis and Repair
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Machine learning for identifying antigen-antibody interactions from massive sequencing data
4mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R21 · $0.5M · Regulatory Landscape of Neurodegeneration by Single-Cell Spatial Multiomics
5mo agoNew grantSource (opens the source filing in a new tab)
NIH R35 · $0.4M · Advanced Single-Cell Protein Analysis with Multiplex in Situ Tagging Array Technology
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Machine learning for identifying antigen-antibody interactions from massive sequencing data
6mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment
7mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R41 · $0.4M · Design and optimization of TCR-T therapeutics by an advanced T cell receptor-antigen binding prediction platform
10mo agoNew grantSource (opens the source filing in a new tab)
Study registered, no phase assigned: Point-of-Care Testing in Outpatient Diabetes Care
10mo agoTrial registeredSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

R21 · $455k · non-dilutive

R41 · $360k · non-dilutive

R01 · $686k · non-dilutive

R01 · $635k · non-dilutive

R61 · $237k · non-dilutive

NA registered

R35 · $394k · non-dilutive

R01 · $452k · non-dilutive

R01 · $578k · non-dilutive

R01 · $615k · non-dilutive